CanAssist Breast, a novel prognostic test for patients with breast cancer, will be exclusively marketed by Zydus Lifesciences
CanAssist Breast, an innovative and highly advanced prognostic test for breast cancer patients in the early stages that aids clinicians in determining whether the patient needs chemotherapy, will be exclusively marketed by global healthcare company Zydus Lifesciences Ltd. Nearly 50% of the 2.1 million cases of breast cancer in India are hormone positive. Many patients